
    
      To assess the safety and performance of the ANTHEMâ„¢ CR Total Knee System in patients with
      degeneration of the knee by demonstrating non-inferiority in the revision-free survival rate
      at 5 years compared to a literature reference rate of 96.6% (Australian Orthopaedic
      Association annual report 2016).
    
  